In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0008-8749(81)90118-0PMID 7214534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.

  1980cited by this paper
• Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide

  1980cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

  1979cited by this paper
• Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

  1979cited by this paper
• Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.

  1979cited by this paper
• Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.

  1979cited by this paper
• Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.

  1979cited by this paper
• The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro.

  1979cited by this paper
• Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells

  1978cited by this paper
• Recognition and destruction of target cells by tumoricidal macrophages.

  1978cited by this paper
• Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein rich fraction of lipopolysaccharides

  1978cited by this paper
• Tumor heterogeneity and the biology of cancer invasion and metastasis.

  1978cited by this paper
• Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide

  1978cited by this paper
• Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.

  1978cited by this paper
• Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).

  1978cited by this paper
• Inhibition of macrophage migration by synthetic muramyl dipeptide.

  1978cited by this paper
• Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

  1977cited by this paper
• Reduction of tumour cell entry into vessels by BCG-activated macrophages.

  1977cited by this paper
• Macrophage tumor killing: influence of the local environment.

  1977cited by this paper
• Modulation of the immune response by a synthetic adjuvant and analogs.

  1976cited by this paper
• Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

  1976cited by this paper
• Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds

  1976cited by this paper
• Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

  1975cited by this paper
• Macrophage activation by lymphocyte mediators.

  1975cited by this paper
• Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

  1975cited by this paper
• Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.

  1975cited by this paper
• Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

  1974cited by this paper
• Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

  1974cited by this paper
• Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

  1972cited by this paper

• Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins

  2022cites this paper
• Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review)

  2022cites this paper
• The Use of Phospholipids to Make Pharmaceutical Form Line Extensions

  2021cites this paper
• Targeting macrophage anti-tumor activity to suppress melanoma progression

  2017influential citation
• Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ

  2014cites this paper
• Innate immune responses of natural killer cells and macrophages against bone sarcomas : towards cellular immunotherapy

  2014cites this paper
• Exosome release of ADAM15 and the functional implications of human macrophage‐derived ADAM15 exosomes

  2012cites this paper
• NONSELECTIVE LYSIS OF TUMOR CELLS BY MACROPHAGES Cell Cultures

  2006cites this paper
• NonselectiveDestructionof MurineNeoplastiaCells by SyngeneicTumoricidal Macrophages 1

  2006cites this paper
• Eradication of Hepatic Métastasesof Carcinoma H-59 by Combination Chemoimmunotherapy with Liposomal Muramyl Tripeptide, 5-Fluorouracil, and Leucovorin1

  2006cites this paper
• Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice

  2005cites this paper
• Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis

  2004cites this paper
• Direct activation of tumoricidal properties in rat alveolar macrophages by Nocardia rubra cell wall skeleton

  2004cites this paper
• A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state

  2004cites this paper
• Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine

  2004cites this paper
• Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cells

  2004cites this paper
• Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide

  2004cites this paper
• Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes

  2004cites this paper
• Antimetastatic effect of immunomodulators from Nocardia opaca in mice and rats activation of peritoneal macrophages by these fractions

  2004cites this paper
• Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptide

  2004cites this paper
• Macrophages in cancer metastases and their relevance to metastatic growth

  2004cites this paper
• Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats

  2004cites this paper
• Effects of immunopotentiating agents on alveolar macrophage properties

  2002cites this paper
• Ligand-targeted liposomes.

  1998cites this paper
• Distribution of liposomes containing mannobiose esters of fatty acid in rats.

  1995cites this paper
• IF YOUR BULLET'S MAGIC, WHAT'S YOUR POISON? Antibody-Directed Liposomes, Liposome-Dependent Drugs, and how they were pursued in the Laboratory of Demetrios Papahadjopoulos

  1995cites this paper
• Influence of synthetic adjuvants on nonspecific resistance to infections.

  1994cites this paper
• Therapy of cancer metastasis by systemic activation of macrophages.

  1994cites this paper
• Beneficial effects of myristic, stearic or oleic acid as part of liposomes on experimental infection and antitumor effect in a murine model.

  1994cites this paper
• Effect of Liposome-Muramyl Tripeptide Combined with Recombinant Canine Granulocyte Colony-Stimulating Factor on Canine Monocyte Activity

  1994cites this paper
• Tumor Cell Binding and Induction of Endothelial Cell Tumoricidal Activity In Vitro by Muramyl Dipeptide Is Enhanced by Liposomal Encapsulation

  1994cites this paper
• Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression.

  1993cites this paper
• Pharmacokinetics of an immunomodulator peptidoglycan monomer in mice after intravenous administration.

  1993cites this paper
• Muramyl Peptides Augment the In Vitro and In Vivo Cytostatic Activity of Canine Plastic-Adherent Mononuclear Cells Against Canine Osteosarcoma Cells

  1993cites this paper
• Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.

  1993cites this paper
• Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.

  1993cites this paper
• Current state of liposome-complexed drugs in the treatment of cancer patients.

  1992cites this paper
• Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock

  1992cites this paper
• Stimulation of Kupffer cell tumoricidal activity by liposomal muramyl dipeptides.

  1992cites this paper
• Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin.

  1992cites this paper
• Phase I Trial of ImmTher, a New Liposome‐Incorporated Lipophilic Disaccharide Tripeptide

  1991cites this paper
• Immunomodulating peptides of natural and synthetic origin.

  1991cites this paper
• Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis.

  1991cites this paper
• Immunomodulating peptides of natural and synthetic origin

  1991cites this paper
• In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362

  1991cites this paper
• In vitro stimulation of immune functions by lipids derived from macrophages exposed to bacterial peptidoglycan.

  1991cites this paper
• [Metastatic dissemination of cancer cells].

  1991cites this paper
• MDP and LPS act synergistically to induce arginine-dependent cytostatic activity in rat alveolar macrophages.

  1991cites this paper
• Liposomal delivery of biological response modifiers to macrophages

  1991cites this paper
• Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.

  1991cites this paper
• Impaired tumoricidal function of alveolar macrophages from patients with non‐small cell lung cancer

  1991cites this paper
• Purification and characterization of N-acetylmuramoyl-L-alanine amidase from human serum.

  1990cites this paper
• Macrophage Activation for Antitumour Function by Muramyl Dipeptide‐protein Conjugates

  1990cites this paper
• Purification and characterization of N-acetylmuramoyl-L-alanine amidase from human serum.

  1990cites this paper
• Immunomodulatory activity of small peptides.

  1990cites this paper
• Macrophages and cancer

  1990cites this paper
• Macrophage phagocytosis of platelet-encapsulated muramyl dipeptide: macrophage/tumour cell cytotoxicity studies.

  1990cites this paper
• The role of cytokines in macrophage activation.

  1990cites this paper
• Therapy of Murine Liver Metastases by Administration of MDP Encapsulated in Liposomes

  1990cites this paper
• Immunomodulatory activity of small peptides.

  1990cites this paper
• Induction of colony-stimulating activity in mice by injection of liposomes containing lipophilic muramyl peptide derivatives.

  1989cites this paper
• Role of Macrophages in Recognition and Destruction of Metastatic Cells

  1989cites this paper
• Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide.

  1989cites this paper
• Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine.

  1989cites this paper
• Activated porcine alveolar macrophages: Are biological response modifiers the answer?

  1989cites this paper
• Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.

  1989cites this paper
• Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity

  1989cites this paper
• Photoaffinity labelling of macrophages and B-lymphocytes using 125I-labelled aryl-azide derivatives of muramyldipeptide.

  1989cites this paper
• Kupffer cells and liver metastasis

  1989cites this paper
• Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide.

  1989cites this paper
• Fourier transform infrared assay of liposomal lipids.

  1989cites this paper
• Endogenous Lectins and Drug Targeting

  1988cites this paper
• Incorporation of LPS in Liposomes Diminishes Its Ability to Induce Tumoricidal Activity and Tumor Necrosis Factor Secretion in Murine Macrophages

  1988cites this paper
• Endogenous Lectins of Myeloid and Tumor Cells: Characterization and Biological Implications

  1988cites this paper
• Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells.

  1988cites this paper
• Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self.

  1988cites this paper
• Preparation and use of liposomes in the treatment of microbial infections.

  1988cites this paper
• Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer

  1988cites this paper
• Eradication of cancer metastasis by tumoricidal macrophages.

  1988cites this paper
• Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide

  1988cites this paper
• Macrophage Activation by a Series of Unique Polnanionic Polymers

  1988cites this paper
• Macrophage therapy of cancer metastasis.

  1988cites this paper
• Activation of macrophage in vitro to acquire antitumor activity by a muramyl dipeptide derivative encapsulated in microspheres composed of lactide copolymer

  1987cites this paper
• Recruitment of exogenous macrophages into metastases at different stages of tumor growth

  1987cites this paper
• The biology of cancer metastasis and implications for therapy.

  1987cites this paper
• Macrophage-Mediated Antitumor Activity Induced by Poly(Itaconic Acid-co-Styrene

  1987cites this paper
• The pulmonary alveolar macrophage and lung cancer.

  1987cites this paper
• Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.

  1987cites this paper
• Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.

  1987cites this paper
• A novel muramyl peptide derivative stimulates tumoricidal activity of macrophages and antibody production by B cells

  1987cites this paper
• Interleukin 1 release by human monocytes treated with liposome-encapsulated lipopolysaccharide.

  1987cites this paper
• Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastases.

  1987cites this paper
• Use of resealed erythrocytes as delivery system for C-reactive protein (CRP) to generate macrophage-mediated tumoricidal activity.

  1987cites this paper
• Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.

  1987cites this paper
• Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages.

  1986cites this paper
• Immunological activities of muramyl peptides.

  1986cites this paper
• Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties.

  1986cites this paper
• In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.

  1986cites this paper
• The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.

  1986cites this paper
• Role of alveolar macrophages in pulmonary neoplasias.

  1986cites this paper